The Global Apraxia Drug Market is poised for moderate but sustained growth, driven by the increasing incidence of neurological disorders (such as stroke, neurodegenerative diseases, and brain injuries) that cause motor planning difficulties. While the mainstay of treatment for apraxia remains speech and occupational therapy, the market for pharmacological intervention—primarily focused on...
"What’s Fueling Executive Summary Apraxia Drug Market Size and Share Growth
The global Apraxia Drug Treatment market was valued at USD 6.68 billion in 2024 and is expected to reach USD 10.02 billion by 2032, at a CAGR of 5.2%, during the forecast period
An influential Apraxia Drug Market document supports in achieving a sustainable growth in the market, by...